Utah Medical Products (UTMD): CEO bought ~$67K

~$67K

Approx. value · 1,000 sh @ $66.75

189K

Holds after · shares reported

Traded

Oct 29, 2026

Filed

Oct 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 22, 2026Company filing · Form 8-K · ResultsReported its results
2. Oct 29, 2026 · this disclosureInsider · First insider buy since Aug 2011CEO purchased ~$67K of UTMD shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Utah Medical Products

For Utah Medical Products, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its UTMD page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans